News
ENOV
27.86
+3.07%
0.83
Weekly Report: what happened at ENOV last week (0720-0724)?
Weekly Report · 4h ago
Weekly Report: what happened at ENOV last week (0713-0717)?
Weekly Report · 07/20 10:17
Is Enovis (ENOV) Undervalued On Its CT RevitL Launch Or Is That Priced In?
Simply Wall St · 07/19 18:13
Is Enovis (ENOV) Using CT-RevitL to Quietly Redefine Its Veterinary Innovation Strategy?
Simply Wall St · 07/17 19:20
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know
Barchart · 07/17 14:58
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis
Barchart · 07/17 08:18
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
Barchart · 07/17 07:00
Enovis Breaks Below 200-Day Moving Average - Notable for ENOV
NASDAQ · 07/14 20:17
Enovis (ENOV) Receives a Buy from Jefferies
TipRanks · 07/14 13:15
Enovis (ENOV) Stock Trades Up, Here Is Why
Barchart · 07/13 12:18
Weekly Report: what happened at ENOV last week (0706-0710)?
Weekly Report · 07/13 10:18
Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care
Barchart · 07/13 07:30
Enovis Initiated at Outperform by BMO Capital
Dow Jones · 07/09 11:02
Enovis Price Target Announced at $29.00/Share by BMO Capital
Dow Jones · 07/09 11:02
BMO Capital Initiates Coverage On Enovis with Outperform Rating, Announces Price Target of $29
Benzinga · 07/09 10:52
Does Enovis (ENOV) Leaving Russell Defensive Indexes Signal A Deeper Shift In Its Risk Profile?
Simply Wall St · 07/09 06:34
BMO starts Enovis at Outperform on accelerating free cash flow conversion
TipRanks · 07/08 20:30
Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus
Simply Wall St · 07/07 23:30
Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update
NASDAQ · 07/07 03:12
Why Enovis (ENOV) Stock Is Trading Up Today
Barchart · 07/06 14:58
More
Webull provides a variety of real-time ENOV stock news. You can receive the latest news about Enovis Corp through multiple platforms. This information may help you make smarter investment decisions.
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).